Details of the Drug

General Information of Drug (ID: DM7SOT3)

• Drug Name: ADP-A2AFP

Indication

Disease Entry	ICD 11	Status	REF
Liver cancer	2C12	Phase 1	[1]

• Drug Type: CAR-T cell therapy
• Cross-matching ID: TTD ID: D31ORV

References

• [1] ClinicalTrials.gov (NCT03132792) A Phase I Open Label Clinical Trial Evaluating the Safety and Anti-Tumor Activity of Autologous T Cells Expressing Enhanced TCRs Specific for Alpha Fetoprotein (AFP????T) in HLA-A2 Positive Subjects With Advanced Hepatocellular Carcinoma (HCC) or Other AFP Expressing Tumor Types. U.S.National Institutes of Health.